Your browser is no longer supported. Please, upgrade your browser.
CTXR Citius Pharmaceuticals, Inc. monthly Stock Chart
Citius Pharmaceuticals, Inc.
Index- P/E- EPS (ttm)-0.55 Insider Own22.20% Shs Outstand41.60M Perf Week-1.71%
Market Cap52.12M Forward P/E2.29 EPS next Y0.41 Insider Trans0.00% Shs Float39.36M Perf Month-14.68%
Income-17.10M PEG- EPS next Q-0.17 Inst Own13.40% Short Float3.34% Perf Quarter-1.11%
Sales- P/S- EPS this Y33.90% Inst Trans3.09% Short Ratio1.73 Perf Half Y7.87%
Book/sh0.69 P/B1.36 EPS next Y177.40% ROA-53.90% Target Price- Perf Year118.21%
Cash/sh0.15 P/C6.13 EPS next 5Y- ROE-69.20% 52W Range0.40 - 1.97 Perf YTD-7.99%
Dividend- P/FCF- EPS past 5Y-6.20% ROI- 52W High-53.79% Beta1.34
Dividend %- Quick Ratio2.40 Sales past 5Y- Gross Margin- 52W Low127.60% ATR0.05
Employees1 Current Ratio2.40 Sales Q/Q- Oper. Margin- RSI (14)37.74 Volatility4.05% 4.60%
OptionableNo Debt/Eq0.01 EPS Q/Q43.80% Profit Margin- Rel Volume0.43 Prev Close0.94
ShortableYes LT Debt/Eq0.01 Earnings- Payout- Avg Volume759.69K Price0.91
Recom2.00 SMA20-6.34% SMA50-10.96% SMA200-4.22% Volume247,309 Change-2.99%
Nov-10-20 09:30AM  
Nov-09-20 09:30AM  
Oct-27-20 09:00AM  
Oct-13-20 07:30AM  
Oct-07-20 07:00AM  
Sep-30-20 09:45AM  
Sep-29-20 10:17AM  
Sep-22-20 08:15AM  
Sep-15-20 10:17AM  
Sep-08-20 10:00AM  
Sep-01-20 04:34PM  
Aug-27-20 09:00AM  
Aug-26-20 10:00AM  
Aug-13-20 09:45AM  
Aug-10-20 03:18PM  
Aug-05-20 05:32PM  
Aug-04-20 08:17AM  
Jul-22-20 10:30AM  
Jul-20-20 02:00PM  
Jul-14-20 08:47AM  
Jul-13-20 08:15AM  
Jun-30-20 08:54AM  
Jun-29-20 09:07AM  
Jun-26-20 09:00AM  
Jun-23-20 08:49AM  
Jun-22-20 01:17PM  
Jun-02-20 09:30AM  
May-26-20 08:15AM  
May-18-20 02:30PM  
May-15-20 06:49AM  
May-14-20 09:00AM  
May-13-20 08:15AM  
May-12-20 08:00AM  
Apr-27-20 09:30AM  
Apr-01-20 08:07AM  
Mar-26-20 09:06AM  
Mar-18-20 09:46AM  
Mar-16-20 06:22AM  
Mar-03-20 04:45PM  
Feb-26-20 08:00AM  
Feb-25-20 08:00AM  
Feb-10-20 08:28AM  
Feb-04-20 08:00AM  
Feb-03-20 08:00AM  
Jan-27-20 08:00AM  
Dec-19-19 08:00AM  
Dec-04-19 08:00AM  
Nov-08-19 08:00AM  
Oct-24-19 08:00AM  
Oct-15-19 08:00AM  
Oct-07-19 08:30AM  
Oct-03-19 07:00AM  
Sep-28-19 07:52AM  
Sep-27-19 11:28AM  
Sep-25-19 07:00AM  
Sep-04-19 06:55AM  
Aug-29-19 08:00AM  
Jul-30-19 08:00AM  
Jul-24-19 03:38PM  
May-24-19 08:53AM  
May-13-19 08:47AM  
May-01-19 08:00AM  
Apr-30-19 09:45AM  
Apr-23-19 08:30AM  
Apr-05-19 07:15PM  
Apr-04-19 08:30AM  
Apr-01-19 09:00AM  
Mar-12-19 08:45AM  
Mar-11-19 02:23PM  
Feb-27-19 12:30PM  
Jan-25-19 08:00AM  
Jan-08-19 09:00AM  
Jan-04-19 10:45AM  
Dec-19-18 09:45AM  
Dec-10-18 08:35AM  
Dec-04-18 08:35AM  
Nov-30-18 08:00AM  
Nov-29-18 04:35PM  
Oct-25-18 08:00AM  
Oct-23-18 08:00AM  
Sep-27-18 08:00AM  
Sep-25-18 08:00AM  
Aug-15-18 08:00AM  
Aug-13-18 05:00PM  
Aug-09-18 01:55PM  
Jul-31-18 09:30AM  
Jul-24-18 08:00AM  
Jul-13-18 10:48AM  
Jul-09-18 08:00AM  
Jun-19-18 08:00AM  
Mar-29-18 08:00AM  
Mar-06-18 08:00AM  
Feb-15-18 08:00AM  
Feb-13-18 08:00AM  
Jan-31-18 08:00AM  
Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. It primarily focuses on developing anti-infective, cancer care, and prescription products. The company develops Mino-Lok, which is in Phase III clinical trials for the treatment and salvage of infected central venous catheters in patients with catheter related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction tissue expander infections following breast reconstructive surgeries; and Hydro-Lido, a topical formulation of hydrocortisone and lidocaine that is intended for the treatment of hemorrhoids. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
affiliate | advertise | contact | privacy | help
Do not sell my personal information

Quotes delayed 15 minutes for NASDAQ, and 20 minutes for NYSE and AMEX.
Copyright © 2007-2020 All Rights Reserved.